Pancreatic cancer has a low survival rate, with a median survival of 20-24 months after early surgery, and should be treated with postoperative chemotherapy or radiation therapy to prolong survival.
Surgery is currently the treatment of choice for people with resectable tumors. Diagnosed and treated at an early stage, the median survival after surgery is about 20-24 months. The 5-year survival rate after early surgery has been reported to be about 5-7%.
However, due to the extremely high mortality rate of pancreatic cancer and the high recurrence rate of pancreatic cancer, which grows extremely fast, adjuvant therapy should be administered after surgery to reduce the risk of distant metastasis as well as local recurrence. Such as chemotherapy, targeted therapy, pain relief therapy, nutritional support and so on.
In order to reduce the incidence of pancreatic cancer, daily exercise, weight control, stop alcohol abuse, pre-cancer screening and early diagnosis and treatment are recommended for people with high risk of pancreatic cancer. Regular review is also needed after surgery.